Kinematik provides machine intelligence solutions specifically for analyzing animal motion. The company utilizes proprietary AI models to automate behavioral analysis for biopharma and animal healthcare organizations. This automation accelerates the discovery process in preclinical research and veterinary science.
Funding
Funding not disclosed
Founders
Product
Problem
Drug development and animal research rely on accurate behavioral analysis, which is traditionally a manual, time-consuming process. This manual analysis can lead to bottlenecks in research, delaying discoveries and increasing costs for biopharma and animal healthcare organizations.
Solution
Kinematik AI offers an AI-powered platform that automates animal behavioral analysis, accelerating discoveries for biopharma and animal healthcare organizations. The platform leverages proprietary AI models to analyze animal motion, providing researchers with detailed, quantitative data. By automating this process, Kinematik AI reduces the time and resources required for behavioral analysis, enabling faster and more efficient research workflows. The platform's AI models are built upon expertise in multimodal, self-supervised, and generative AI, incorporating technologies such as DeepLabCut, CEBRA, and wav2vec.
Target Audience
The primary customers are biopharma and animal healthcare organizations involved in drug development and animal research.
Features
- AI-driven analysis of animal motion using proprietary models.
- Automation of behavioral analysis workflows, reducing manual effort.
- Integration of multimodal, self-supervised, and generative AI techniques.
- Based on technologies such as DeepLabCut, CEBRA, and wav2vec.